Proficio Capital Partners LLC Increases Stock Position in Zoetis Inc. (NYSE:ZTS)

Proficio Capital Partners LLC raised its stake in shares of Zoetis Inc. (NYSE:ZTSFree Report) by 6.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,761 shares of the company’s stock after acquiring an additional 169 shares during the quarter. Proficio Capital Partners LLC’s holdings in Zoetis were worth $467,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in ZTS. Blue Bell Private Wealth Management LLC boosted its stake in Zoetis by 222.5% during the 4th quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock valued at $25,000 after acquiring an additional 89 shares during the last quarter. Webster Bank N. A. boosted its stake in Zoetis by 89.1% during the 1st quarter. Webster Bank N. A. now owns 174 shares of the company’s stock valued at $29,000 after acquiring an additional 82 shares during the last quarter. Independence Bank of Kentucky boosted its stake in Zoetis by 371.4% during the 4th quarter. Independence Bank of Kentucky now owns 165 shares of the company’s stock valued at $33,000 after acquiring an additional 130 shares during the last quarter. Private Wealth Management Group LLC bought a new position in Zoetis during the 4th quarter valued at $33,000. Finally, Ramirez Asset Management Inc. bought a new position in Zoetis during the 3rd quarter valued at $35,000. 92.80% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

ZTS has been the topic of a number of recent research reports. Piper Sandler restated an “overweight” rating and issued a $195.00 price target (down from $220.00) on shares of Zoetis in a research report on Tuesday, April 16th. HSBC reduced their price target on shares of Zoetis from $230.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, May 8th. Stifel Nicolaus reduced their price target on shares of Zoetis from $195.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. The Goldman Sachs Group reduced their price target on shares of Zoetis from $223.00 to $196.00 and set a “buy” rating on the stock in a research report on Monday, May 6th. Finally, Barclays reduced their price target on shares of Zoetis from $260.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 23rd. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, Zoetis has a consensus rating of “Buy” and an average target price of $211.75.

Read Our Latest Analysis on ZTS

Zoetis Stock Performance

Shares of ZTS stock traded down $2.29 during trading hours on Wednesday, reaching $171.95. The stock had a trading volume of 312,428 shares, compared to its average volume of 2,894,558. The company has a debt-to-equity ratio of 1.30, a current ratio of 3.33 and a quick ratio of 1.94. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The firm has a 50-day simple moving average of $171.62 and a 200-day simple moving average of $177.52. The firm has a market capitalization of $78.46 billion, a PE ratio of 33.57, a price-to-earnings-growth ratio of 2.72 and a beta of 0.86.

Zoetis (NYSE:ZTSGet Free Report) last released its earnings results on Thursday, May 2nd. The company reported $1.38 EPS for the quarter, beating the consensus estimate of $1.34 by $0.04. The firm had revenue of $2.19 billion for the quarter, compared to analysts’ expectations of $2.14 billion. Zoetis had a net margin of 27.38% and a return on equity of 50.34%. Zoetis’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS. As a group, equities analysts forecast that Zoetis Inc. will post 5.76 earnings per share for the current year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 4th. Shareholders of record on Thursday, July 18th will be paid a dividend of $0.432 per share. The ex-dividend date of this dividend is Thursday, July 18th. This represents a $1.73 annualized dividend and a yield of 1.00%. Zoetis’s payout ratio is 33.33%.

Insider Buying and Selling at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 923 shares of the firm’s stock in a transaction dated Thursday, April 18th. The shares were sold at an average price of $151.17, for a total transaction of $139,529.91. Following the transaction, the executive vice president now owns 14,800 shares of the company’s stock, valued at approximately $2,237,316. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.16% of the stock is owned by corporate insiders.

Zoetis Company Profile

(Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Read More

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTSFree Report).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.